» Articles » PMID: 38251293

Medicalization of Sport? A Mixed-Method Study on the Use of Medications in Elite Ice Hockey

Overview
Journal Sports (Basel)
Publisher MDPI
Specialty Public Health
Date 2024 Jan 22
PMID 38251293
Authors
Affiliations
Soon will be listed here.
Abstract

Ice hockey is a high-risk sport known for its dominant macho culture. The purpose of this study was to examine experiences surrounding medication use among male, elite ice hockey players in Norway. A mixed-method design was employed, which first examined medications registered on doping control forms (DCFs) ( = 177) and then involved semi-structured focus group interviews ( = 5) with elite athletes ( = 25). Overall, 68% of the DCFs contained information about ≥1 medication. Among the most registered medications were NSAIDs and hypnotics (20% and 19% of all DCFs, respectively). During the interviews, numerous athletes reported using analgesics to manage injuries and pain caused by the sport, often being motivated by sacrificing themselves for the team during important matches and playoffs. Hypnotics were used due to high cumulative stress due to heavy training and competition load, late-night matches, and playing in a semi-professional league. Athlete support personnel (ASP), including physicians and trainers, were the athletes' main sources of information. The athletes often displayed a profound and non-critical trust in the advice and products provided to them by their team physician. The findings indicate that male, elite ice hockey players, through their excessive and somewhat ignorant use of medications, expose themselves to health risks and inadvertent doping.

Citing Articles

Experiences of health information-seeking behaviour in preoperative patients with lung cancer: a qualitative study in China.

Guo J, Zhu J, Huang L, Li W, Ye M BMJ Open. 2025; 15(2):e090540.

PMID: 39909525 PMC: 11800196. DOI: 10.1136/bmjopen-2024-090540.


Motivations for Using Dietary Supplements in Elite Ice Hockey-Controlling Weight and Enhancing Performance.

Christensen S, Gjelstad A, Bjornsdottir I, Lauritzen F Nutrients. 2024; 16(16).

PMID: 39203804 PMC: 11357155. DOI: 10.3390/nu16162667.

References
1.
Lauritzen F, Gjelstad A . Trends in dietary supplement use among athletes selected for doping controls. Front Nutr. 2023; 10:1143187. PMC: 10050343. DOI: 10.3389/fnut.2023.1143187. View

2.
Corrigan B, Kazlauskas R . Medication use in athletes selected for doping control at the Sydney Olympics (2000). Clin J Sport Med. 2003; 13(1):33-40. DOI: 10.1097/00042752-200301000-00007. View

3.
Mottram D, Chester N, Atkinson G, Goode D . Athletes' knowledge and views on OTC medication. Int J Sports Med. 2008; 29(10):851-5. DOI: 10.1055/s-2008-1038403. View

4.
Mazanov J, Backhouse S, Connor J, Hemphill D, Quirk F . Athlete support personnel and anti-doping: Knowledge, attitudes, and ethical stance. Scand J Med Sci Sports. 2013; 24(5):846-56. DOI: 10.1111/sms.12084. View

5.
Gaetz M . Substance availability and use in ex-professional ice hockey enforcers. Sci Rep. 2022; 12(1):22204. PMC: 9789070. DOI: 10.1038/s41598-022-26806-7. View